Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: A competing risk analysis

Abnormal glucose and lipids levels may impact survival after breast cancer (BC) diagnosis, but their association to other causes of mortality such as cardiovascular (CV) disease may result in a competing risk problem.